Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jun;34(6):851-6.
doi: 10.1007/s00296-013-2838-5. Epub 2013 Aug 10.

Gastrointestinal manifestations of Behçet's disease in Japan: a study of 43 patients

Affiliations

Gastrointestinal manifestations of Behçet's disease in Japan: a study of 43 patients

Haruko Ideguchi et al. Rheumatol Int. 2014 Jun.

Abstract

We analyzed the clinical gastrointestinal (GI) characteristics of Behçet's disease (BD) patients in Japan. We retrospectively reviewed the clinical charts of 412 patients who fulfilled the 1987 Japanese criteria for BD and were treated in two university hospitals from July 1991 to December 2007. Forty-three patients (10.4 %) had BD-related GI lesions, which were shown by imaging examinations. Median age at BD diagnosis and onset of GI episodes were 29.6 and 31.0 years, respectively. The patients suffered from abdominal pain (30/43) and GI bleeding (18/43), while they had lower frequency of eye involvement and higher incidence of arthritis and vascular involvement than BD patients without GI lesions. The lesions were prevalent in the ileum (32/43) followed by cecum (21/43) and esophagus (9/43). The patients were treated with mesalazine and sulfasalazine (41/43), corticosteroids (32/43), immunosuppressants (13/43), and infliximab for 7 patients having refractory lesions, while 10 patients had surgical operation. Two patients died due to non-GI events during the observation. The diagnosis of BD was often difficult because of lack of eye involvement. Surgery is required for some patients in spite of intensive immunosuppressive therapies. Appropriate use of anti-TNF agents may be promising for the GI involvement.

PubMed Disclaimer

References

    1. Medicine (Baltimore). 2011 Mar;90(2):125-132 - PubMed
    1. Dis Colon Rectum. 2000 May;43(5):692-700 - PubMed
    1. J Korean Med Sci. 2001 Oct;16(5):615-8 - PubMed
    1. N Engl J Med. 1999 Oct 21;341(17):1284-91 - PubMed
    1. Haematologica. 1980 Jun;65(3):381-3 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources